Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at giving a third COVID-19 vaccine for people who didn’t have a good response (OCTAVE-DUO)

Overview

Cancer types:

All cancer types

Status:

Results

Phase:

Phase 3

Details

This trial looked at giving a 3rd COVID-19 vaccine injection to people whose wasn’t working well.

The trial was for people with some types of cancer and other ongoing (chronic) health conditions. And their to the first two vaccines was low.

It was open for people to join between 2021 and 2022. The team published the results in 2024.

Recruitment start: 4 August 2021

Recruitment end: 31 March 2022

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Iain McInnes

Supported by

Blood Cancer UK

Medical Research Council (MRC)

UK Research and Innovation (UKRI)

University of Birmingham

University of Glasgow

Last reviewed: 28 January 2025

CRUK internal database number: 17564

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.